Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | Director | September 11, 2020 | September 15, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date September 11, 2020 · Filed September 15, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Comp Plan Baxter Common Stock FundSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-09-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-09-11 · Other · Disposed 11,894 · Balance 0 F1: 1 for 1 F2: Reporting person transferred shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: 1 for 1
F2: Reporting person transferred shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2020 Filed Sep 15, 2020 20:09 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | OtherDeferred Comp Plan Baxter Common Stock Fund · Derivative | 11,894 | $83.10 | $988,391.40 |
DisclosureSEC source: 0001220966-20-000003 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 11,894 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: Reporting person transferred shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.exercise_date: Reporting person transferred shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person transferred shares from the Baxter Common Stock Fund ("Fund") notional investment alternative under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") as the Fund will be eliminated as an investment alternative effective October 1, 2020. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,789 | $0.00 Strike: $37.50 | $0.00 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · derivative · entry 6 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 10,789 shares Expires 2025-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Gavin. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,110 | $0.00 Strike: $39.83 | $0.00 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · derivative · entry 5 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,110 shares Expires 2024-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Gavin. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 3,351 | $86.91 | $291,235.41 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · nonDerivative · entry 4 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,508 F3 · kind: Price reflects weighted average sales price. Range of prices for transactions are $ 86.82 through $86.96. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 11,548 | $86.26 | $996,130.48 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · nonDerivative · entry 3 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,859 F2 · kind: Price reflects weighted average sales price. Range of prices for transactions are $ 85.80 through $86.80. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 10,789 | $37.50 | $404,587.50 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · nonDerivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Gavin. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:39 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 4,110 | $39.83 | $163,701.30 |
DisclosureSEC source: 0000899243-20-021491 · doc4.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to certain vested stock options previously granted by Baxter International Inc. ("BII") to Mr. Gavin. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001220966-20-000001 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,402 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,930 | $0.00 Strike: $36.93 | $0.00 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · derivative · entry 5 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 3,930 shares Expires 2023-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,020 | $0.00 Strike: $29.52 | $0.00 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · derivative · entry 4 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,020 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 7,950 | $87.63 | $696,658.50 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · nonDerivative · entry 3 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,912 F1 · price: Price reflects weighted average sales price. Range of prices for transactions are $87.63 through $87.64. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 3,930 | $36.93 | $145,134.90 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · nonDerivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 20:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 4,020 | $29.52 | $118,670.40 |
DisclosureSEC source: 0001220966-19-000005 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2019 Filed Jul 10, 2019 20:33 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 65 | $81.58 | $5,302.70 |
DisclosureSEC source: 0001220966-19-000004 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,803 Underlying: Common Stock, $1 par value · 65 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:22 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 70 | $75.44 | $5,280.80 |
DisclosureSEC source: 0001220966-19-000003 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,714 Underlying: Common Stock, $1 par value · 70 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:07 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001220966-19-000002 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,813 F1 · shares: Dr. Gavin elected to defer 100% of his 2019 annual equity grant in the form of fully vested Baxter International Inc. ("BII") common stock pursuant to the BII's Director's Deferred Compensation Plan, amended May 2019, and subject to the terms and conditions of such grant. Read SEC document |
| January 14, 2019 Filed Jan 16, 2019 22:32 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 73 | $66.12 | $4,826.76 |
DisclosureSEC source: 0001220966-19-000001 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,632 Underlying: Common Stock, $1 par value · 73 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:49 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxer Common Stock Fund · Derivative | 73 | $65.83 | $4,805.59 |
DisclosureSEC source: 0001220966-18-000005 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,530 Underlying: Common Stock, $1 par value · 73 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 20:37 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 47 | $72.07 | $3,387.29 |
DisclosureSEC source: 0001220966-18-000004 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,427 Underlying: Common Stock, $1 par value · 47 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 47 | $71.68 | $3,368.96 |
DisclosureSEC source: 0001220966-18-000003 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,384 Underlying: Common Stock, $1 par value · 47 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Directors' Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:19 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 6,437 | $0.00 Strike: $69.45 | $0.00 |
DisclosureSEC source: 0001220966-18-000002 · edgar.xml · derivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,437 Underlying: Common Stock, $1 par value · 6,437 shares Expires 2028-05-08 F2 · derivative.exercise_date: The reporting person received a grant of 6,437 fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:19 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,332 | $69.45 | $92,507.40 |
DisclosureSEC source: 0001220966-18-000002 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,051 F1 · shares: The reporting person received a grant of 1,332 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,990 | $0.00 Strike: $31.26 | $0.00 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · derivative · entry 10 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,990 shares Expires 2021-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by BII to Mr. Gavin on May 3, 2011. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,320 | $0.00 Strike: $24.27 | $0.00 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · derivative · entry 9 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,320 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by BII to Mr. Gavin on May 4, 2010. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,680 | $0.00 Strike: $26.77 | $0.00 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · derivative · entry 8 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 5,680 shares Expires 2019-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by BII to Mr. Gavin on May 5, 2009. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,760 | $0.00 Strike: $33.77 | $0.00 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · derivative · entry 7 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 3,760 shares Expires 2018-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Gavin on May 6, 2008. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 1,700 | $65.06 | $110,602.00 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · nonDerivative · entry 6 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,638 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by BII to Mr. Gavin. F7 · price: Price reflects weighted average sales price. Range of prices for transactions are $65.00 through $65.21. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 17,050 | $64.51 | $1,099,895.50 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · nonDerivative · entry 5 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,338 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by BII to Mr. Gavin. F6 · price: Price reflects weighted average sales price. Range of prices for transactions are $63.99 through $64.99. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 4,990 | $31.26 | $155,987.40 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · nonDerivative · entry 4 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by BII to Mr. Gavin on May 3, 2011. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 4,320 | $24.27 | $104,846.40 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · nonDerivative · entry 3 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by BII to Mr. Gavin on May 4, 2010. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 5,680 | $26.77 | $152,053.60 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · nonDerivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by BII to Mr. Gavin on May 5, 2009. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 20:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 3,760 | $33.77 | $126,975.20 |
DisclosureSEC source: 0001220966-18-000001 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Gavin with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Gavin on May 6, 2008. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:52 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 9,027 | $0.00 Strike: $55.68 | $0.00 |
DisclosureSEC source: 0001220966-17-000003 · edgar.xml · derivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,027 Underlying: Common Stock, $1 par value · 9,027 shares Expires 2027-05-02 F2 · derivative.exercise_date: The reporting person received a grant of fully vested Company stock options, subject to the terms and conditions of the applicable grant. Read SEC document |
| May 02, 2017 Filed May 4, 2017 20:52 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,616 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001220966-17-000003 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,393 F1 · price: The reporting person received a grant of 1,616 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| March 29, 2017 Filed Mar 30, 2017 20:12 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,280 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0001220966-17-000002 · edgar.xml · derivative · entry 3 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,280 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Dr. Gavin with respect to the stock options granted by Baxter International Inc. to Dr. Gavin on May 1, 2007. Read SEC document |
| March 29, 2017 Filed Mar 30, 2017 20:12 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 4,280 | $51.72 | $221,361.60 |
DisclosureSEC source: 0001220966-17-000002 · edgar.xml · nonDerivative · entry 2 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,700 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Dr. Gavin with respect to the stock options granted by Baxter International Inc. to Dr. Gavin on May 1, 2007. Read SEC document |
| March 29, 2017 Filed Mar 30, 2017 20:12 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 4,280 | $30.73 | $131,524.40 |
DisclosureSEC source: 0001220966-17-000002 · edgar.xml · nonDerivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Dr. Gavin with respect to the stock options granted by Baxter International Inc. to Dr. Gavin on May 1, 2007. Read SEC document |
| January 20, 2017 Filed Jan 23, 2017 21:27 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 227 | $46.23 | $10,494.21 |
DisclosureSEC source: 0001220966-17-000001 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,290 Underlying: Common Stock, $1 par value · 227 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 20:14 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 233 | $48.18 | $11,225.94 |
DisclosureSEC source: 0001220966-16-000011 · edgar.xml · derivative · entry 1 GAVIN JAMES R III · CIK 0001220966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,953 Underlying: Common Stock, $1 par value · 233 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Non-Employee Director Deferred Compensation Plan to the Baxter Common Stock Fund notional investment alternative. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.